9 Bipolar Disorder Clinical Trials in Little Rock, AR (2026)

Q: How do I join a clinical trial in Little Rock?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Little Rock research site will contact you.

Recruiting Bipolar Disorder Studies in Little Rock

NCT06929273Recruiting

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

This is a phase 3, open-label extension study to assess the long-term safety of KarXT for the treatment of mania or mania with mixed features in Bipolar-I disorder (BP-I) The primary objective of the...

Little Rock, ARPHASE3450 participantsBristol-Myers Squibb

View Study Details

NCT07140913Recruiting

A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

The purpose of this study is to evaluate the efficacy and safety of adjunctive KarXT for the treatment of mania in participants with Bipolar-I Disorder....

Little Rock, ARPHASE3424 participantsBristol-Myers Squibb

View Study Details

NCT07172516Recruiting

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

X-CEED is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of azetukalner in adult participants diagnosed with bipolar I or II disorder wh...

Little Rock, ARPHASE3400 participantsXenon Pharmaceuticals Inc.

View Study Details

NCT06372964Recruiting

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients who are experiencing major depressive episodes (MDEs) associated with a primary diagnosis of bipolar I o...

Little Rock, ARPHASE3384 participantsIntra-Cellular Therapies, Inc.

View Study Details

NCT07494305Recruiting

Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.

Phase II study for patients with Bipolar 1 Disorder experiencing major depressive episode. Patient eligible for enrollment will be randomized (like flipping a coin) to either active drug (LB-102 or pl...

Little Rock, ARPHASE2320 participantsLB Pharmaceuticals Inc.

View Study Details

NCT06951711Recruiting

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

This is a Phase 3, randomized, double-blind, placebo-controlled, multicenter, inpatient study in participants with bipolar disorder experiencing an acute episode of mania or mania with mixed features....

Little Rock, ARPHASE3274 participantsBristol-Myers Squibb

View Study Details

NCT06951698Recruiting

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder

The purpose of this study is to evaluate the efficacy and safety of KarXT for the treatment of manic episodes in Bipolar-I Disorder...

Little Rock, ARPHASE3274 participantsBristol-Myers Squibb

View Study Details

NCT06656416Recruiting

ALTO-100 in Bipolar Disorder With Depression (BD-D)

The purpose of this study is to assess antidepressant efficacy differences between ALTO-100 and placebo during the Double-Blind period in patients with bipolar disorder I or II with current major depr...

Little Rock, ARPHASE2200 participantsAlto Neuroscience

View Study Details

NCT07288320Recruiting

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania

The primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving manic symptoms in adults with bipolar I disorder who are currently experiencing an ep...

Little Rock, ARPHASE2150 participantsNeurocrine Biosciences

View Study Details

About Bipolar Disorder Clinical Trials in Little Rock

Bipolar disorder is a mental health condition marked by extreme mood swings including emotional highs (mania or hypomania) and lows (depression). It affects about 2.8% of adults in the U.S. Treatment typically involves mood stabilizers, antipsychotics, and psychotherapy.

There are currently 9 bipolar disorder clinical trials recruiting participants in Little Rock, AR. These studies are seeking a combined 2,876 participants. Research is being sponsored by Bristol-Myers Squibb, Xenon Pharmaceuticals Inc., Intra-Cellular Therapies, Inc. and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Bipolar Disorder Clinical Trials in Little Rock — FAQ

Are there bipolar disorder clinical trials in Little Rock?

Yes, there are 9 bipolar disorder clinical trials currently recruiting in Little Rock, AR. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Little Rock?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Little Rock research site will contact you about next steps.

Are clinical trials in Little Rock free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Little Rock studies also compensate for your time and travel.

What bipolar disorder treatments are being tested?

The 9 active trials in Little Rock are testing new therapies including novel drugs, biologics, and treatment approaches for bipolar disorder.

Data updated October 12, 2026 from ClinicalTrials.gov